CWA
MLAB icon

CM Wealth Advisors’s Mesa Laboratories MLAB Stock Holding History

CM Wealth Advisors’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$830K Buy
+8,341
New +$840K 0.15% 66

Other funds holding MLAB

LPP
Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

CM Wealth Advisors's MLAB Position: Q2 2026 in Review

CM Wealth Advisors opened a new position in Mesa Laboratories (MLAB) in Q2 2026: 8,341 shares worth $830K. The stake represents 0.15% of the portfolio and ranks #66 among its holdings.

159 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • CM Wealth Advisors held 8,341 shares of Mesa Laboratories worth $830K as of Q2 2026.
  • Mesa Laboratories was a new CM Wealth Advisors position in Q2 2026.
  • Mesa Laboratories made up 0.15% of CM Wealth Advisors's portfolio in Q2 2026, its #66 holding.
  • 159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on CM Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.